Quantitative proteomics: TGFβ2 signaling in trabecular meshwork cells.

Kathryn Elizabeth Bollinger, John S. Crabb, Xianglin Yuan, Tasneem Putliwala, Abbot F. Clark, John W. Crabb

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Transforming growth factor beta 2 (TGFβ2) is often elevated in the aqueous humor (AH) and trabecular meshwork (TM) of patients with primary open-angle glaucoma (POAG) and appears to contribute to POAG pathogenesis. To better understand TGFβ2 signaling in the eye, TGFβ2-induced proteomic changes were identified in cells cultured from the TM, a tissue involved in intraocular pressure (IOP) elevation in glaucoma. Primary cultures of human TM cells from four donors were treated with or without TGFβ2 (5 ng/mL) for 48 hours; then cellular protein was analyzed by liquid chromatography-mass spectrometry iTRAQ (isobaric tags for relative and absolute quantitation) technology. A total of 853 proteins were quantified. TGFβ2 treatment significantly altered the abundance of 47 proteins, 40 of which have not previously been associated with TGFβ2 signaling in the eye. More than half the 30 elevated proteins support growing evidence that TGFβ2 induces extracellular matrix remodeling and abnormal cytoskeletal interactions in the TM. The levels of 17 proteins were reduced, including four cytoskeletal and six regulatory proteins. Both elevated and decreased regulatory proteins implicate TGFβ2-altered processes involving transcription, translation, and the glutamate/glutamine cycle. Altered levels of eight mitochondrial proteins support TGFβ2-induced mitochondrial dysfunction in the TM that in POAG could contribute to oxidative damage in the AH outflow pathway, TM senescence, and elevated IOP. The results expand the repertoire of proteins known to participate in TGFβ2 signaling, provide new molecular insight into POAG, and establish a quantitative proteomics database for the TM that includes candidate glaucoma biomarkers for future validation studies.

Original languageEnglish (US)
Pages (from-to)8287-8294
Number of pages8
JournalInvestigative ophthalmology & visual science
Volume52
Issue number11
DOIs
StatePublished - 2011

Fingerprint

Trabecular Meshwork
Transforming Growth Factor beta
Proteomics
Proteins
Aqueous Humor
Intraocular Pressure
Glaucoma
Validation Studies
Mitochondrial Proteins
Glutamine
Liquid Chromatography
Extracellular Matrix
Glutamic Acid
Cultured Cells
Mass Spectrometry
Biomarkers
Tissue Donors
Databases
Technology

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

Quantitative proteomics : TGFβ2 signaling in trabecular meshwork cells. / Bollinger, Kathryn Elizabeth; Crabb, John S.; Yuan, Xianglin; Putliwala, Tasneem; Clark, Abbot F.; Crabb, John W.

In: Investigative ophthalmology & visual science, Vol. 52, No. 11, 2011, p. 8287-8294.

Research output: Contribution to journalArticle

Bollinger, Kathryn Elizabeth ; Crabb, John S. ; Yuan, Xianglin ; Putliwala, Tasneem ; Clark, Abbot F. ; Crabb, John W. / Quantitative proteomics : TGFβ2 signaling in trabecular meshwork cells. In: Investigative ophthalmology & visual science. 2011 ; Vol. 52, No. 11. pp. 8287-8294.
@article{47b339302a5747ffa18aa4e20904b1d8,
title = "Quantitative proteomics: TGFβ2 signaling in trabecular meshwork cells.",
abstract = "Transforming growth factor beta 2 (TGFβ2) is often elevated in the aqueous humor (AH) and trabecular meshwork (TM) of patients with primary open-angle glaucoma (POAG) and appears to contribute to POAG pathogenesis. To better understand TGFβ2 signaling in the eye, TGFβ2-induced proteomic changes were identified in cells cultured from the TM, a tissue involved in intraocular pressure (IOP) elevation in glaucoma. Primary cultures of human TM cells from four donors were treated with or without TGFβ2 (5 ng/mL) for 48 hours; then cellular protein was analyzed by liquid chromatography-mass spectrometry iTRAQ (isobaric tags for relative and absolute quantitation) technology. A total of 853 proteins were quantified. TGFβ2 treatment significantly altered the abundance of 47 proteins, 40 of which have not previously been associated with TGFβ2 signaling in the eye. More than half the 30 elevated proteins support growing evidence that TGFβ2 induces extracellular matrix remodeling and abnormal cytoskeletal interactions in the TM. The levels of 17 proteins were reduced, including four cytoskeletal and six regulatory proteins. Both elevated and decreased regulatory proteins implicate TGFβ2-altered processes involving transcription, translation, and the glutamate/glutamine cycle. Altered levels of eight mitochondrial proteins support TGFβ2-induced mitochondrial dysfunction in the TM that in POAG could contribute to oxidative damage in the AH outflow pathway, TM senescence, and elevated IOP. The results expand the repertoire of proteins known to participate in TGFβ2 signaling, provide new molecular insight into POAG, and establish a quantitative proteomics database for the TM that includes candidate glaucoma biomarkers for future validation studies.",
author = "Bollinger, {Kathryn Elizabeth} and Crabb, {John S.} and Xianglin Yuan and Tasneem Putliwala and Clark, {Abbot F.} and Crabb, {John W.}",
year = "2011",
doi = "10.1167/iovs.11-8218",
language = "English (US)",
volume = "52",
pages = "8287--8294",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "11",

}

TY - JOUR

T1 - Quantitative proteomics

T2 - TGFβ2 signaling in trabecular meshwork cells.

AU - Bollinger, Kathryn Elizabeth

AU - Crabb, John S.

AU - Yuan, Xianglin

AU - Putliwala, Tasneem

AU - Clark, Abbot F.

AU - Crabb, John W.

PY - 2011

Y1 - 2011

N2 - Transforming growth factor beta 2 (TGFβ2) is often elevated in the aqueous humor (AH) and trabecular meshwork (TM) of patients with primary open-angle glaucoma (POAG) and appears to contribute to POAG pathogenesis. To better understand TGFβ2 signaling in the eye, TGFβ2-induced proteomic changes were identified in cells cultured from the TM, a tissue involved in intraocular pressure (IOP) elevation in glaucoma. Primary cultures of human TM cells from four donors were treated with or without TGFβ2 (5 ng/mL) for 48 hours; then cellular protein was analyzed by liquid chromatography-mass spectrometry iTRAQ (isobaric tags for relative and absolute quantitation) technology. A total of 853 proteins were quantified. TGFβ2 treatment significantly altered the abundance of 47 proteins, 40 of which have not previously been associated with TGFβ2 signaling in the eye. More than half the 30 elevated proteins support growing evidence that TGFβ2 induces extracellular matrix remodeling and abnormal cytoskeletal interactions in the TM. The levels of 17 proteins were reduced, including four cytoskeletal and six regulatory proteins. Both elevated and decreased regulatory proteins implicate TGFβ2-altered processes involving transcription, translation, and the glutamate/glutamine cycle. Altered levels of eight mitochondrial proteins support TGFβ2-induced mitochondrial dysfunction in the TM that in POAG could contribute to oxidative damage in the AH outflow pathway, TM senescence, and elevated IOP. The results expand the repertoire of proteins known to participate in TGFβ2 signaling, provide new molecular insight into POAG, and establish a quantitative proteomics database for the TM that includes candidate glaucoma biomarkers for future validation studies.

AB - Transforming growth factor beta 2 (TGFβ2) is often elevated in the aqueous humor (AH) and trabecular meshwork (TM) of patients with primary open-angle glaucoma (POAG) and appears to contribute to POAG pathogenesis. To better understand TGFβ2 signaling in the eye, TGFβ2-induced proteomic changes were identified in cells cultured from the TM, a tissue involved in intraocular pressure (IOP) elevation in glaucoma. Primary cultures of human TM cells from four donors were treated with or without TGFβ2 (5 ng/mL) for 48 hours; then cellular protein was analyzed by liquid chromatography-mass spectrometry iTRAQ (isobaric tags for relative and absolute quantitation) technology. A total of 853 proteins were quantified. TGFβ2 treatment significantly altered the abundance of 47 proteins, 40 of which have not previously been associated with TGFβ2 signaling in the eye. More than half the 30 elevated proteins support growing evidence that TGFβ2 induces extracellular matrix remodeling and abnormal cytoskeletal interactions in the TM. The levels of 17 proteins were reduced, including four cytoskeletal and six regulatory proteins. Both elevated and decreased regulatory proteins implicate TGFβ2-altered processes involving transcription, translation, and the glutamate/glutamine cycle. Altered levels of eight mitochondrial proteins support TGFβ2-induced mitochondrial dysfunction in the TM that in POAG could contribute to oxidative damage in the AH outflow pathway, TM senescence, and elevated IOP. The results expand the repertoire of proteins known to participate in TGFβ2 signaling, provide new molecular insight into POAG, and establish a quantitative proteomics database for the TM that includes candidate glaucoma biomarkers for future validation studies.

UR - http://www.scopus.com/inward/record.url?scp=84856488883&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856488883&partnerID=8YFLogxK

U2 - 10.1167/iovs.11-8218

DO - 10.1167/iovs.11-8218

M3 - Article

C2 - 21917933

AN - SCOPUS:84856488883

VL - 52

SP - 8287

EP - 8294

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 11

ER -